Engineers Gate Manager’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-94,244
| Closed | -$23.3K | – | 2566 |
|
|
2026
Q1 | $23.3K | Buy |
94,244
+37,690
| +67% | +$15K | ﹤0.01% | 2116 |
|
|
2025
Q4 | $23.8K | Sell |
56,554
-185,909
| -77% | -$98.5K | ﹤0.01% | 2022 |
|
|
2025
Q3 | $163K | Buy |
242,463
+155,038
| +177% | +$83.6K | ﹤0.01% | 1948 |
|
|
2025
Q2 | $47.3K | Buy |
87,425
+44,078
| +102% | +$26.2K | ﹤0.01% | 2051 |
|
|
2025
Q1 | $28.4K | Sell |
43,347
-11,592
| -21% | -$12.3K | ﹤0.01% | 2069 |
|
|
2024
Q4 | $56K | Buy |
54,939
+9,499
| +21% | +$17.4K | ﹤0.01% | 2070 |
|
|
2024
Q3 | $39.4K | Sell |
45,440
-11,115
| -20% | -$8.14K | ﹤0.01% | 1994 |
|
|
2024
Q2 | $20.3K | Buy |
56,555
+1,618
| +3% | +$874 | ﹤0.01% | 1854 |
|
|
2024
Q1 | $36.8K | Sell |
54,937
-1,618
| -3% | -$1.17K | ﹤0.01% | 1820 |
|
|
2023
Q4 | $30.7K | Buy |
56,555
+17,436
| +45% | +$8.04K | ﹤0.01% | 1882 |
|
|
2023
Q3 | $23.5K | Sell |
39,119
-2,992
| -7% | -$3.2K | ﹤0.01% | 1699 |
|
|
2023
Q2 | $54.7K | Buy |
+42,111
| New | +$57.5K | ﹤0.01% | 1616 |
|
|
2022
Q4 | – | Sell |
-16,290
| Closed | -$80K | – | 1997 |
|
|
2022
Q3 | $80K | Buy |
+16,290
| New | +$83.7K | 0.01% | 1467 |
|
|
2022
Q2 | – | Sell |
-50,600
| Closed | -$294K | – | 2223 |
|
|
2022
Q1 | $294K | Buy |
50,600
+22,500
| +80% | +$134K | 0.01% | 1410 |
|
|
2021
Q4 | $211K | Sell |
28,100
-3,808
| -12% | -$33.1K | 0.01% | 1622 |
|
|
2021
Q3 | $287K | Sell |
31,908
-20,516
| -39% | -$203K | 0.02% | 1220 |
|
|
2021
Q2 | $628K | Buy |
52,424
+29,144
| +125% | +$330K | 0.04% | 708 |
|
|
2021
Q1 | $292K | Buy |
+23,280
| New | +$314K | 0.01% | 1335 |
|
|
2020
Q4 | – | Sell |
-92,845
| Closed | -$877K | – | 1951 |
|
|
2020
Q3 | $877K | Buy |
92,845
+13,421
| +17% | +$145K | 0.04% | 691 |
|
|
2020
Q2 | $712K | Buy |
+79,424
| New | +$737K | 0.04% | 768 |
|
Other funds holding SGMO
AIM
HIG
Engineers Gate Manager's SGMO Position: Q2 2026 in Review
Engineers Gate Manager sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 94,244 shares — an estimated $23.3K sold.
Engineers Gate Manager first reported a position in SGMO in Q2 2020 and held it in 20 quarters. The position peaked at $877K in Q3 2020. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.
- Engineers Gate Manager reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
- Engineers Gate Manager sold 94,244 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $23.3K.
- Engineers Gate Manager first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 20 quarters.
- Engineers Gate Manager's SANGAMO THERAPEUTICS INC position peaked at $877K in Q3 2020.
- 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.